MCD vs NERV · P/E 23, rev $25.92B vs P/E 2.2, $12.4M cap
McDonald’s Corporation (MCD) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the MCD and NERV stock pages for the full models.
Not investment advice.